Cancer News and Research

Latest Cancer News and Research

Genetically engineered bugs to fight cancer

GENETICALLY engineered bacteria could become the latest weapons against cancer, Cancer Research UK scientists suggest in a study published today 22nd April 2004.

22 Apr 2004

Coalition forms to promote 75 cent tobacco tax increase

A new coalition called the Health Leaders Alliance (HLA) has been formed in Michigan to formally support HB 5632, sponsored by Representative Larry Julian (R), which includes Governor Granholm's proposal for a 75 cent tobacco tax increase.

21 Apr 2004

Scientists have discovered an exciting new target in the fight to stop the spread of cancer cells

Scientists at The Institute of Cancer Research have discovered an exciting new target in the fight to stop the spread of cancer cells which could significantly improve treatment by replacing traditional chemotherapy.

20 Apr 2004

Protein on the centrosome key to new strategies for stopping cancer growth

A Mayo Clinic discovery about a protein known as Dynamin-2 has thrown conventional wisdom for a loop. Finding the protein on the centrosome, a minute structure near a cell’s nucleus, may lead to new strategies for stopping cancer growth.

20 Apr 2004

Possible breakthrough in AIDS and cancer research

Mayo Clinic researchers have found a way to revive immunity in mice that have abnormal or deficient immune systems. The discovery may lead to a means of restoring immunity to individuals with immunodeficiency diseases such as AIDS and cancer.

20 Apr 2004

New drug is effective at treating patients in the early stages of Parkinson’s

An international team of Parkinson’s disease researchers has shown that a potential new drug is effective at treating patients in the early stages of Parkinson’s and may even slow the progression of the disease.

20 Apr 2004

Dieting greatly reduces risk of heart attack, stroke and diabetes

People who severely restrict their caloric intake drastically reduce their risk of developing diabetes or clogged arteries, the precursor to a heart attack or stroke. In fact, according to researchers at Washington University School of Medicine in St Louis, some risk factors were so low they were comparable to those of people decades younger.

20 Apr 2004

Can public health promotion beat disease?

Huge efforts are under way to address health problems such as SARS, HIV, diabetes and many other illnesses by developing vaccines or therapeutic drugs.

20 Apr 2004

Researchers use IBM Linux supercomputing cluster to research DNA

Researchers at Mount Allison University are working to better understand how human DNA is damaged and what drugs can be used to repair it, using a powerful IBM Linux supercomputing cluster.

20 Apr 2004

Link between iron regulation and the immune system

Patients with chronic inflammatory disorders, including infections, inflammatory bowel disease, arthritis and cancer, commonly become anemic. The anemia can make them sicker, is sometimes severe enough to require a blood transfusion, and responds only partially to current treatments.

20 Apr 2004

Dietary supplement may improve immune function in the elderly

A recent clinical study has demonstrated that 7-oxo Dehydroepiandrosterone taken orally twice daily by healthy adults over a period of one month augments several key T-cell mediated immune function parameters compared to placebo administration.

20 Apr 2004

New developments in the treatment of pancreatic cancer

A booster dose of a substance already found in the body appears to be safe and non-toxic for the treatment of pancreatic cancer, and shows signs of arresting pancreatic cancer cell growth in patients, Penn State College of Medicine researchers report.

20 Apr 2004

Pfizer donates £1 million Brighton and Sussex Medical School

Brighton and Sussex Medical School (BSMS) is pleased to announce that it has received a £1 million donation from pharmaceutical company, Pfizer (UK).

20 Apr 2004

Functional genomics provide improved drug discovery

Functional genomics and proteomics have been quite successful in identifying functions of potential therapeutic targets such as encoded proteins.

20 Apr 2004

Myriad Genetics advances drug for chemotherapy-induced nausea

Myriad Genetics, Inc. today released new data on MPC-4505, its Neurokinin-1 (NK1) receptor antagonist, a drug candidate for chemotherapy-induced nausea and vomiting (emesis). MPC-4505 is a potent, orally bioavailable, CNS-penetrating, highly selective NK1 antagonist.

20 Apr 2004

Solvent used in nail polish may increase risk of breast and ovarian cancer

Ethylene glycol methyl ether a solvent for nitrocellulose, oils and resins, adhesives and for many different purposes may raise the risk of breast or ovarian cancer among women taking hormone treatments, say researchers at Duke University.

19 Apr 2004

Strict dieting can dramatically reduce the risk of heart disease

19 Apr 2004

44 countries to hammer out global health issues at Earth Observation Summit

44 countries will hammer out plans for sharing outbreak data at the Earth Observation Summit meeting, to be held Sunday in Tokyo.

19 Apr 2004

Preclinical data on Histamine's ability to prevent liver damage

These new results demonstrate the ability of histamine to prevent LPS-induced liver injury in a rodent model by showing efficacy when delivered in a manner mimicking oral administration.

19 Apr 2004

Proteomics helps fight colon cancer

Using new technology associated with the study of proteins, or proteomics, scientists at the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), and their colleagues have made a step toward predicting which people with familial adenomatous polyposis.

19 Apr 2004